SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-008981
Filing Date
2017-08-11
Accepted
2017-08-11 17:02:29
Documents
63
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 557870
2 ex31-1.htm EX-31.1 8763
3 ex31-2.htm EX-31.2 8811
4 ex32-1.htm EX-32.1 4841
5 ex32-2.htm EX-32.2 4910
  Complete submission text file 0001493152-17-008981.txt   3039293

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cdxi-20170630.xml EX-101.INS 456538
7 XBRL SCHEMA FILE cdxi-20170630.xsd EX-101.SCH 38683
8 XBRL CALCULATION FILE cdxi-20170630_cal.xml EX-101.CAL 45190
9 XBRL DEFINITION FILE cdxi-20170630_def.xml EX-101.DEF 130147
10 XBRL LABEL FILE cdxi-20170630_lab.xml EX-101.LAB 290917
11 XBRL PRESENTATION FILE cdxi-20170630_pre.xml EX-101.PRE 225091
Mailing Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822
Business Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822 808-457-1400
CARDAX, INC. (Filer) CIK: 0001544238 (see all company filings)

IRS No.: 454484428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-181719 | Film No.: 171025895
SIC: 2834 Pharmaceutical Preparations